VVTMF (VVT Med) EBIT per Share: $-0.04 (TTM As of Sep. 2025)


VVTMF VVT Med Inc VVTMF
6 GF Score
Price $0.02
! 4 Warning Signs
View Full Analysis

What is VVT Med EBIT per Share?

VVT Med VVTMF 6 EBIT per Share is $-0.04 as of Sep. 2025. GuruFocus rates VVTMF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 690 Medical Devices & Instruments companies, VVT Med ranks worse than 144927.39% on this metric.

VVT Med's EBIT per Share for the three months ended in Sep. 2025 was $-0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for VVT Med's EBIT per Share or its related term are showing as below:

VVTMF's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

VVT Med's EBIT for the three months ended in Sep. 2025 was $-2.21 Mil.


VVT Med  (OTCPK:VVTMF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


VVT Med EBIT per Share Related Terms


VVT Med EBIT per Share Historical Data

* Premium members only.

The historical data trend for VVT Med's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VVT Med EBIT per Share Chart

VVT Med Annual Data
Trend Dec22 Dec23 Dec24
EBIT per Share
-0.04 -0.03 -0.01

VVT Med Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EBIT per Share Get a 7-Day Free Trial Premium Member Only -0.01 0.00 -0.01 -0.01 -0.03
VVTMF
6GF Score
VVT Med Inc VVTMF
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VVT Med EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

VVT Med's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

EBIT per Share(A: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.639/66.640
=-0.01

VVT Med's EBIT per Share for the quarter that ended in Sep. 2025 is calculated as

EBIT per Share(Q: Sep. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.211/66.311
=-0.03

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.04 mean?
VVT Med (VVTMF) has a EBIT per Share of $-0.04 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on VVT Med and its competitors. According to the industry distribution chart, VVT Med ranks #999999 out of 690 companies in the Medical Devices & Instruments industry.
Is VVT Med's EBIT per Share too high?
VVT Med's current EBIT per Share is $-0.04. Based on the distribution chart, VVT Med ranks #999999 out of 690 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VVT Med has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #999999 out of 690 companies for EBIT per Share. This places VVT Med in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on VVT Med and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current EBIT per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current EBIT per Share of $-0.04. The current EBIT per Share is $-0.04. VVT Med's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For VVT Med (VVTMF), the current EBIT per Share is $-0.04 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VVT Med Business Description

Other Exchanges VVTM:Canada
Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
6GF Score

Get the complete analysis for VVTMF

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price